Seven-Year MiSight® 1 day Contact Lens Study Indicates No Myopia Control Rebound in Children

CooperVision announced new seven-year findings from its pivotal MiSight® 1 day contact lens clinical trial Twelve months following treatment...

Read More

Essilor Receives FDA “Breakthrough Device” Designation for Essilor Stellest

Essilor announced that the US Food and Drug Administration (FDA) has granted “Breakthrough Device” designation to its Essilor Stellest™...

Read More

Etnia Barcelona Foundation Partners with Vons Vision to Aid in Eye Examinations for Children and Students

Etnia Barcelona Foundation, in collaboration with Vons Vision, will be partnering with 5 local optometrists to aid in eye examinations for children...

Read More